2 enrolling by invitation. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Enrolling by invitation 2 |
Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis Sonelokimab - Arthritis, Psoriatic | Phase 3 | Enrolling by invitation | MoonLake Immunotherapeutics AG | 1560 | 2025-11-13 | 2026-09-09 |
| Sulodexide in Controlling the Recurrence of Psoriasis Sulodexide, Placebo - Psoriasis (PsO), Randomised Controlled Trial | Phase 3 | Enrolling by invitation | Xijing Hospital | 160 | 2025-04-20 | 2025-05-21 |
Skin Diseases (2) · Skin Diseases, Papulosquamous (2) · Skin and Connective Tissue Diseases (2) · Arthritis (1) · Bone Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Spinal Diseases (1) · Spondylarthritis (1) · Spondylarthropathies (1) · Spondylitis (1)
glucuronyl glucosamine glycan sulfate (1) · sonelokimab (1)
MoonLake Immunotherapeutics AG (1) · Xijing Hospital (1)
China (1) · United States (1)
Gang Wang (1)
PMID 31595056, PMID 31899186, PMID 32365242, PMID 32427307, PMID 32888954, PMID 33812489, PMID 33995668, PMID 35601055, PMID 36917196